Alpha Tau Medical (DRTS) Net Cash Flow (2021 - 2022)
Alpha Tau Medical's (DRTS) quarterly Net Cash Flow came in at -$86.3 million in Q2 2022, down 214.92% quarter-over-quarter from $75.1 million in Q1 2022.
Alpha Tau Medical (DRTS) Net Cash Flow (2021 - 2022) Analysis & Trends
Alpha Tau Medical has disclosed Net Cash Flow across 2 years of filings, most recently posting -$86.3 million for Q2 2022.
- Net Cash Flow for Q2 2022 came in at -$86.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was -$86.3 million (down 214.92% YoY), and the FY2025 annual result was -$1.5 million, down 248.61% from the prior year.
- Net Cash Flow came in at -$86.3 million for Q2 2022 at Alpha Tau Medical, down from $75.1 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $75.1 million in Q1 2022 to a low of -$86.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 664,983.53 |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -86.31 Mn |
| Jun 30, 2022 | -86.31 Mn |
| Mar 31, 2022 | 75.10 Mn |
| Mar 31, 2022 | 75.10 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Mar 31, 2021 | -3.74 Mn |